The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- USDH’s AI-Driven Colonoscopy Innovation and Market Expansion: A Disruptive Force in U.S. Preventive Medicine (AInvest)
- Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition (MedCity News)
- How to protect physician autonomy as GI consolidates (Becker’s GI & Endoscopy)
- GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine (ScienceDirect)
- 288 new CPT codes cover digital health, AI and more (AMA)
- The Prognostic Power of ctDNA Testing in Patients With Colorectal Cancer (Medscape)
- AI Is Becoming Private Equity’s New Playbook (Forbes)
- Rising colorectal cancer rates and ASCs: 5 things to know (Bevker’s GI & Endoscopy)
